Privileged scaffolds in medicinal chemistry: Studies on pyrazolo[1,5-a]pyrimidines on sulfonamide containing Carbonic Anhydrase inhibitors
| dc.authorid | 0000-0001-6459-7692 | en_US |
| dc.contributor.author | Gümüş, Arzu | |
| dc.contributor.author | Bozdağ, Murat | |
| dc.contributor.author | Angeli, Andrea | |
| dc.contributor.author | Peat, Thomas S. | |
| dc.contributor.author | Carta, Fabrizio | |
| dc.contributor.author | Supuran, Claudiu T. | |
| dc.contributor.author | Selleri, Silvia | |
| dc.date.accessioned | 2022-06-08T11:06:49Z | |
| dc.date.available | 2022-06-08T11:06:49Z | |
| dc.date.issued | 2021 | en_US |
| dc.department | Fakülteler, Fen-Edebiyat Fakültesi, Kimya Bölümü | en_US |
| dc.description | Gümüş, Arzu (Balikesir Author) | en_US |
| dc.description.abstract | We report for the first time a small series of compounds endowed in vitro with inhibitory properties for the human (h) expressed Carbonic Anhydrase (CAs, E.C. 4.2.1.1) enzymes of physiological interest (i.e. I, II, VA, IX and XII) and bearing the pyrazolo[1,5-a]pyrimidine (PP) scaffold at the tail section. Among the series reported, 1a-3a, 7a, 8a, 1b and 2b resulted effective ligands and with good selectivities for the hCAs II, IX or XII. In consideration of the nearly matching K-I values of 7a for both the hCA II and IX (i.e. 26.4 and 23.0 nM respectively) we explored its binding mode within the CA IX mimic isoform by means of X-ray crystal experiments on the corresponding adduct. | en_US |
| dc.description.sponsorship | Fondazione Cassa Risparmio Firenze ECR2018.1001 | en_US |
| dc.identifier.doi | 10.1016/j.bmcl.2021.128309 | |
| dc.identifier.endpage | 6 | en_US |
| dc.identifier.issn | 0960-894X | |
| dc.identifier.issn | 1464-3405 | |
| dc.identifier.scopus | 2-s2.0-85112394795 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 1 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2021.128309 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12462/12320 | |
| dc.identifier.volume | 49 | en_US |
| dc.identifier.wos | WOS:000696625300003 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | en_US |
| dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
| dc.relation.ispartof | Bioorganic and Medicinal Chemistry Letters | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.relation.tubitak | "info:eu-repo/grantAgreement/TUBITAK/" | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
| dc.subject | Pyrazolopyrimidines | en_US |
| dc.subject | Carbonic Anhydrase Inhibitors | en_US |
| dc.subject | Privilege Scaffolds | en_US |
| dc.subject | X-ray Crystallography | en_US |
| dc.title | Privileged scaffolds in medicinal chemistry: Studies on pyrazolo[1,5-a]pyrimidines on sulfonamide containing Carbonic Anhydrase inhibitors | en_US |
| dc.type | Article | en_US |












